Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (104 ops.)
Latest filing published 06 Aug 2019 for Tandem Diabetes Care INC, €455k.
Filing timeline
BuySaleHoward e. Greene Jr.
Insider track record
Disclosed buys
1
Disclosed sells
104
Signal history
Closed purchases
Market purchases
1
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +1871.2%Entry US$2.50 · Close at T+365 US$49.28
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Howard e. Greene Jr.: trading record in brief
This profile gathers the share dealings of Howard e. Greene Jr. across 3 companies, led by Amylin Pharmaceuticals Inc, Biosite Inc and Tandem Diabetes Care Inc. The record holds 121 filings, for trades running from 3 January 2006 to 5 August 2019.
The open-market side counts 1 purchase for €82k alongside 104 sales for €15.0M. On balance, insiders were net sellers of €14.9M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 13 option exercises. So far in 2019, the count stands at no purchases and 6 sales.
On 6 August 2019 came the latest disclosure, an open-market sale for €455k in Tandem Diabetes Care Inc. The last purchase on record was published on 13 February 2018, which is 3,175 days ago. Typically, a trade is published a median of 1 day after it takes place. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Howard e. Greene Jr.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations119 total
8,325 shares@ US$61.4230.3% of flowCommon StockSEC:0001209191-19-044796:0
1,675 shares@ US$61.926.2% of flowCommon StockSEC:0001209191-19-044796:1
1,200 shares@ US$63.114.2% of flowCommon StockSEC:0001209191-19-015149:0
800 shares@ US$64.302.9% of flowCommon StockSEC:0001209191-19-015149:1
5,600 shares@ US$65.6820.5% of flowCommon StockSEC:0001209191-19-015149:2
2,400 shares@ US$66.218.8% of flowCommon StockSEC:0001209191-19-015149:3
11,787 shares@ US$36.5323.9% of flowCommon StockSEC:0001209191-18-057617:0
50,000 shares@ US$2.005.2% of flowCommon StockSEC:0001209191-18-009610:0
Canonical exit: 10 May 2018 (T+90)
20,000 shares@ US$12.70Common StockSEC:0001209191-15-063677:0
136,672 shares0Common StockSEC:0001209191-13-053621:0
3,700 shares@ US$28.74Common StockSEC:0001367982-08-000074:0
10,000 shares@ US$4.38Common StockSEC:0001367982-08-000070:0
3,700 shares@ US$32.08Common StockSEC:0001367982-08-000038:0
3,700 shares@ US$33.08Common StockSEC:0001367982-08-000036:0
3,700 shares@ US$35.55Common StockSEC:0001367982-08-000010:0
3,700 shares@ US$38.23Common StockSEC:0001367982-07-000484:0
3,700 shares@ US$39.05Common StockSEC:0001367982-07-000472:0
3,700 shares@ US$39.05Common StockSEC:0001367982-07-000464:0
3,700 shares@ US$40.44Common StockSEC:0001367982-07-000460:0
3,700 shares@ US$46.46Common StockSEC:0001367982-07-000444:0
3,700 shares@ US$47.90Common StockSEC:0001367982-07-000436:0
3,700 shares@ US$49.54Common StockSEC:0001367982-07-000406:0
3,700 shares@ US$47.88Common StockSEC:0001367982-07-000388:0
3,700 shares@ US$49.50Common StockSEC:0001367982-07-000382:0
3,700 shares@ US$48.92Common StockSEC:0001264124-07-000007:0
25 of 119 declarations
